Picture of JW (Cayman) Therapeutics Co logo

2126 JW (Cayman) Therapeutics Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: JW (Cayman) Therapeutics Announces Potential Further Strategic Partnership With 2Seventy Bio

Sept 12 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * POTENTIAL FURTHER STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO,
INC.
    * ANNOUNCE ITS INTENTION TO EXPAND ITS STRATEGIC ALLIANCE
WITH
2SEVENTY BIO, INC
    * COLLABORATION BUILDS UPON CO AND 2SEVENTY BIO'S
TRANSLATIONAL
AND CLINICAL CELL THERAPY DEVELOPMENT PLATFORM
    * CO AND 2SEVENTY BIO INTEND TO CO-DEVELOP FURTHER
CANDIDATES FROM
PORTFOLIO OF 2SEVENTY BIO
    * POTENTIAL COLLABORATION WITH 2SEVENTY BIO, INC. MAY OR MAY
NOT
PROCEED 

Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on JW (Cayman) Therapeutics Co

See all news